Japan study tour
Release time:
2020-07-22
focuses on improvement, standards, and refinement. altruism
this tour experience
recently visited Japan with the research group and went to Toyota TPS lean practice dojo for training and study. around the theme of lean management, Toyota company and its suppliers and manufacturers in Nagoya, Shizuoka, Tokyo and other places were visited on the spot.
was the reward itinerary arranged by the head goose class. I didn't expect much at the beginning, but with the change of mentality from passive to devotion, my group members and I constantly felt that Japan's development had entered a stage of highly developed civilization. Whether it is economic, political, cultural, or national quality, we have a big gap with them. We must always reflect on ourselves, police and encourage ourselves, learn from Japan's strengths, and solve internal and external problems through continuous learning and improvement, so as to seize the opportunity to achieve better development.
Here, I will share what I have seen, heard, learned and thought during my stay in Japan from the aspects of Japan's economy, culture and lean management of enterprises.
1. face up to the gap between the economic development of the two countries
In 1991 , Japan entered a long-term economic downturn after the bubble economy burst. Many enterprises were deeply trapped in the economic quagmire, including the AVEX company we visited. In these 20 years, China has prospered and developed. Our Chinese people's clothing, food, housing and transportation have been continuously upgraded, and earth-shaking changes have taken place. We can eat and drink every day like the Chinese New Year, but are we really developed?
As early as 1987 , Japan's GDP surpassed the former Soviet Union to become the world's second largest economy, when the domestic market economy was only a few years old? How many years has it been since the farmland was distributed to the household? After 2008 , the GDP between China and Japan began to approach, and after 2010 , China surpassed Japan to become the world's second largest economy. China is indeed developing rapidly, but we cannot compare the current economic development achievements with the long-term downturn of the Japanese economy, so as to blindly and confidently look down on Japan.
The accompanying translators and local tour guides on this trip are all Chinese who have lived in Japan for more than 20 years. Through their introduction and exchange, we will compare what we have seen and heard between China and Japan from time to time, as well as the enterprises of both sides. The accompanying Tian Translator is also a senior management consultant and is often invited to teach for some companies in China. He said, "Japan has a complete social security system, and employees' working hours are stable at 7-8 hours without worrying about education, medical care and housing prices. But every time I go to China to see the working conditions of front-line workers, I feel very sad. " But it is this kind of "sad " that makes more and more Chinese entrepreneurs and executives have a strong and urgent need to change their business management.
Although China's total economic volume has surpassed that of Japan, China's land area is 25 times that of Japan, and its population is more than 10 times that of Japan. Simply put, Japan is the area of Yunnan Province, but I need not say much about Japan's economic influence, and everyone understands it. The advantages of Japan's economy are prominently reflected in three aspects: industrial manufacturing, financial strength and technological advantages, which are the three pillars for Japan to maintain world economic hegemony.
As of 2019 , Japan has a total of 33259 100-year-old enterprises and 8 millennium-old enterprises. Among the world's ,500 companies, Japan has a total of 68 multinational companies on the list, second only to the United States. Toyota, Mitsubishi, Nissan, Sony, Toshiba, Panasonic and other world-renowned companies and brands are all world-renowned for their product technical content and quality excellence. Mr. Tian said that Japanese products rarely have quality problems, let alone fake and shoddy products. Hearing this, I feel a little burnt on my face. Made in Japan seems to be synonymous with brand, technology and quality. What about made in China?
2. attaches importance to the gap in culture and education between the two countries
10 January 9 , Japanese chemist Akira Yoshino won the 2019 Nobel Prize in Chemistry. He is Japan's 27 Nobel Prize winner. The well-known Kyoto University in Japan has produced 15 Nobel Prize winners.
It is said that the Japanese government decided on a scientific plan in 2001 with the slogan "Win 30 Nobel Prize in 50 " . Previously, in the 100-year history of the Nobel Prize, Japan had only 9 winners, but from 2001 to 2019 , Japan had 18 winners. According to the rhythm of one year at a time, "50 years 30 " is almost no suspense.
The frequent Nobel Prize winning of Japanese can let us see the essence through the phenomenon: Japan is not really struggling. The so-called loss of the Japanese economy 118 20 years, in a sense, is definitely the 120 of their scientific and technological innovation 20 years. Whoever has the most advanced technology can dominate the development trend of the industry. The Nobel Prize is a powerful weapon developed by Japan, even a shining blade. During the visit to Dafu Group, I was very shocked by what the narrator said, "The two storage systems we visited last have not yet been put into the market because our customer units still have a lot of manual links, but we are ready to meet the development of the times! " Yes, when we say we must strive to be prepared for the change, our neighbors are ready!
AVEX , we also learned that the company was hit hard by the world financial crisis of 2008 , but there was no layoff as we imagined. Instead, we spent more energy on personnel training and technological innovation. After ten years of sharpening, AVEX production of gearbox spool products occupy the first place in the world, supplied to Toyota, Aisin, BMW and other car companies, as well as many Chinese car companies. Isn't this a retreat?
Japanese yen is a famous Japanese biologist, Ichiya Higuchi on the 140 5000 Japanese yen is a famous Japanese writer, and the person with firm eyes and serious face on the largest denomination 10000 Japanese yen is educator and thinker Yukichi Fukuzawa. There is no general or emperor in the Japanese yen. Through this subtle way, Japan tells the public that scholars must be respected and education must be valued. Only science and education can rejuvenate the country. Japanese university teachers will not worry about being left out or losing their jobs because they have not produced scientific research results for a period of time. In the research process, they are rarely interfered by the government and society, such as assessment and evaluation. Long-term concentration on academic research. Of course, Japan is basically a lifelong career country. Many countries, especially China and the United States, believe that talents can only be valuable if they move, but this statement obviously does not exist in Japan.
The two teachers who did the Toyota TPS
41 years and retired to the second-line training. Director Ishigaki Zhongzheng was originally responsible for the production and management of Land Cruisers in Toyota's own factory, and now Toyota is doing talent training. It is understood that Japanese employees will receive paid pre-job training for 3-12 months before starting their jobs. Toyota's training cycle is 6 months and Mitsubishi's 12 months. These professionally trained employees will be able to adapt to their jobs as soon as they take up their jobs. This established corporate training system in the Japanese workplace is beyond our ability to afford. Although some large state-owned enterprises in China have also begun to do pre-job training, they have not made long-term systematization like Japanese enterprises. Fortunately, Tencent, Ali and Huawei have deeply realized the important task of rejuvenating enterprises and the country through science and education. This year Tencent has awarded 1.5
scientists. It is hoped that more and more young scholars will turn their attention to academic research and devote themselves to scientific research and innovation. This road is very difficult, but someone must go. (To be continued) (Ye Liqing)
More information
Yunnan peak through the safety standard secondary acceptance
On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate
2020
07-30
Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory
News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.
2020
07-31
Peak health marketing and a new "play"
Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)
2020
07-31
Peak health marketing and a new "play"
Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)
2020
07-31
Accident-free factory creation enters "second season"
At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open
2020
07-31
What will the Chinese Medicine Act bring us?
At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page